Clinical Trial Update: Interferon α for the Therapy of Minimal Residual Disease [NA]

View source ↗

Summary

Clinical trial update investigating interferon alpha for treating minimal residual disease in leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Interferon (interferon)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Leukemia | NA | Status: UNKNOWN